HAEMOTOLOGICAL DISORDERS IN PREGNANCY - PowerPoint PPT Presentation

About This Presentation
Title:

HAEMOTOLOGICAL DISORDERS IN PREGNANCY

Description:

Dr. RAMYA MODERATOR : Dr.PALLAVEE ETIOLOGY Severe def. of VON WILLIBRAND FACTOR ( cleaving protein ( ADAM TS13) Acqd autoantibody Congenital Genetic defect ... – PowerPoint PPT presentation

Number of Views:152
Avg rating:3.0/5.0
Slides: 72
Provided by: nagercoilo
Category:

less

Transcript and Presenter's Notes

Title: HAEMOTOLOGICAL DISORDERS IN PREGNANCY


1
HAEMOTOLOGICAL DISORDERS IN PREGNANCY
  • Dr. RAMYA
  • MODERATOR Dr.PALLAVEE

2
HAEMOTOLOGICAL DISORDERS IN PREGNANCY ANAEMIA PL
ATELET DISORDERS HAEMOGLOBINOPATHIES INHERITED
COAGULATION DEFECTS
3
ANAEMIA Commonest haematological disorder occur
in preg. Prevalance in pregnant women 14 -
Developed 51 - Developing
countries 65-75 - India 80 leading to maternal
deaths
4
DEFINITION Reduction in circulating Hb mass
lt 12g/dl in non-pregnant women lt10 g/dl in
pregnant women CDC Anaemia in iron supplemented
preg. Woman Hct 33 Hb 11g/dl 1st 3rd
trimester Hct 32 Hb 10.5 g / dl - 2nd trimester
5
  • WHO grading of anemia
  • Mild 10g/dl
  • Moderate 7- 10 g/dl
  • Severe lt 7 g/dl

6
ICMR GRADING
Range in g/dl
MILD 10 10.9
MODERATE 7 9.9
SEVERE lt 7
VERY SEVERE lt 4
7
Hemotological Changes in preg.
8
Physiological Anemia of pregnancy
  • Plasma volume s 40-50
  • RBC mass s 30
  • As a result Hb concentration decreases by 2g/dl
  • Decreased Hb concn. Is due to haemodilution
  • Criteria of Physiological Anemia
  • 1) Hb 10 gm
  • 2)RBC 3.2 million cells / cu mm
  • 3)PCV 32
  • 4)Peripheral Smear Normal morphology

9
Classification of Anaemia
10
Classification .
11
Classification .
12
Classification .
13
Classification .
14
ERYTHROPOISES
15
IRON METABOLISM
16
  • IRON Requirements during Pregnancy
  • Maternal req. Of total Iron -1000mg
  • 500 mg ? Mat. Hb. Mass expansion
  • 300 mg ? Fetus Placenta
  • 200mg ? Shed through gut urine, skin

17
DEVELOPMENT OF Iron def. anemia
  • Iron Deficiency Anemia 3 stages
  • a)Depletion of Iron stores
  • b)Iron deficient erythropoiesis
  • c)Frank Iron deficiency Anemia

18
  • Symptoms of IRON DEFICIENCY ANEMIA
  • Fatigue
  • Weakness
  • Headache
  • Loss of appetite
  • Dysphagia
  • Palpitations
  • Dyspnea on exertion
  • Ankle swelling
  • Paresthesias
  • Leukoplakia

19
  • Physical examination
  • Pallor of varying degrees (Mucous membranes ,
    nail beds Koilonychia or Platynychia
  • Glossitis
  • Stomatitis
  • Heart murmurs
  • Increased JVP
  • Tachycardia
  • Tachypnea
  • Postural hypotension
  • Crepitations- due to lung congestion

20
  • Depletion of Iron stores
  • Ferritin lt20 ng/ml
  • Hb / Hct. Normal
  • RBC INDICES normal
  • Iron deficient erythropoiesis
  • Ferritin lt20 ng/ml
  • Transferrin saturationlt25
  • Hb Normal
  • Serum Iron lt 60mg/dl

21
  • c)Frank Iron deficiency Anemia
  • ferritin lt20 ng/ml
  • Transferrin saturationlt25
  • Serum iron lt60 mg/dl
  • Hb lt10g/dl, Hct.lt28

22
Microcytic Hypochromic
23
PROPHYLAXIX
  • WHO - 60 mg Elemental iron 400 micro gram
    Folic acid / day 6 months 3 months postpartum
  • National Nutritional Anemia Control Programme of
    India
  • - 60 mg elemental Iron 500 mcg Folic acid
    Prophylactic supplementation 100 days in 2nd
    trimester

24
Iron Supplements
25
  • Ferrous sulphate 300mg Tid orally daily after
    meals
  • To be contd for 12 months after anemia is
    corrected
  • Indicators of iron therapy response
  • Increase in Reticulocyte count (Increases 3-5
    days after initiation of therapy )
  • Increase in Hb levels. Hb increases 0.3 to 1 g/
    week
  • 3 .Epithelial changes (esp tongue nail ) revert
    to normal
  • Hb concn. Is normal after 6 wks of therapy

26
PARENTERAL ADMINISTRATION
  • INDICATIONS
  • Intolerance to oral iron
  • Non compliance pt.
  • Inflammatory bowel disease
  • Pt. unable to absorb iron orally
  • Patients near term

27
  • TDI Total Dose Infusion
  • Amount of iron needed to restore Hb conc
    to normal additional allowance to provide
    adequate replenishment of iron stores
  • Formulae
  • 1 Total Dose ( mg )
  • ( normal Hb Pts Hb
    ) (body wt. in

  • kg ) 2.21
  • 2 Total Iron Dose (mg )
  • 2.3 wt. kg before
    preg D (Target Hb) 500 mg for
    body store

28
MEGALOBLASTIC ANAEMIA
  • Incidence 0.2 5
  • Caused by folic acid deficiency Vit B12
    deficiency

29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
  • Folic Acid Defciency
  • Pathophysiology
  • Preg. Causes 20 -30 fold increase in Folate
    requirement (150-450 microgram / day ) to meet
    needs of fetus placenta.
  • Placenta transports folate actively to fetus even
    if the mother is deficient.
  • This cause decreased plasma folate levels.

33
  • Causes of Folic acid deficiency
  • 1.Diet- Poor intake, prolonged cooking.
  • 2. Malabsorption Coeliac disease.
  • 3.Increased demand Pregnancy, cell
    proliferation (hemolysis )
  • 4.Drugs anticonvulsants, contraceptive pill,
    cytotoxic drugs (Methotrexate )
  • 5.Diminished storage Hepatic disorders Vit C
    deficiency

34
  • Diagnostic features of Folic acid deficiency
  • 1.Serum Folate levels Low lt3 ng/ml
  • 2.Erythrocyte Folate levels - lt20 ng/ml
  • 3.Peripheral smear Hypersegmented
    neutrophils,Oval macrocytes,Pancytopenia

35
  • Treatment
  • Pregnancy induced megaloblastic anaemia-
  • Folic acid, nutritious diet
    Iron .
  • Supplementation of 1mg of folic acid daily can
    improve MA by 7 to 10 days
  • Folic acid should be given with iron
  • Ascorbic acid 100mg Tid ?enhances action
  • In other conditions
  • Recommended folic acid dose 5mg /day orally
    daily
  • Prophylaxis
  • WHO 400 micrograms folic acid daily to prevent
    neural tube defects

36
Vit B12 Deficiency
37
Pathophysiology
  • Vit B12 absorption is unaltered during pregnancy
  • Tissue uptake is increased ? Decreased serum
    B12
  • Recommended B12 intake 3 microgram /day.
  • CAUSES of Vit B12 def.
  • Strict Veg. diet
  • Use of proton pump inhibitors
  • Metformin.
  • Gastritis
  • Gastrectomy
  • Ileal bypass
  • Crohns
  • H. Pylori infection

38
Pathogenisis of PERNICIOUS ANEMIA ?
Gastric juice IF Antibody
39
Clinical manifestations
  • Macrocytic Megaloblastic Anemia
  • Glossitis
  • Peripheral neuropathy
  • Subacute combined degeneration of the Spinal cord

40
  • DIAGNOSIS
  • Ser.Vit B12 levels ,100 pg /ml
  • Radio active Vit B12 absorption test . (
    Schilling Test )
  • Treatment
  • 1000 microgram parenteral cyanocobalamin every wk
    6 weeks
  • Pernicious Anaemia Oral Vit B12
  • Total Gastrectomy 1000 microgram Vit B12 im
    every month.
  • Partial gastrectomy Ser. Vit B12 levels
    measured.

41
ANAEMIA ASSOC. WITH CHRONIC INFECTIONS / DISEASE
  • Common in developing countries
  • Poor response to Haematinics unless primary cause
    is treated
  • Worm infestations is common ( Diagnosed by stool
    examination )
  • Urinary tract inf, asymptomatic bacteriuria in
    preg. Is assoc. with refractory anaemia
  • Chronic renal disorders due to erythropoietin
    def.
  • Treated with recombinant Erythropoitin

42
Anaemia from acute blood loss
  • In preg. Abortion , ectopic preg, hydatidform
    mole, PPH
  • Treatment.
  • Blood transfusion
  • Indicated patient symptomatic
  • Not indicated If hemodynamically stable, Hb lt 7
    g/dl, able to ambulate without adverse symptoms
    not septic.

43
Acquired hemolytic anemia
  • AUTOIMMUNE HEMOLYTIC ANEMIA
  • AUTOANTI-BODIES OF iGg OR WARM ANTIBODIES AGAINST
    Red cell antigens, causes premature destruction
    of RBCs
  • ETIOLOGY
  • Lymphomas,Leukemias , Connective tissue diseases,
    Infections , Chronic. Inflammatory diseases
    drug induced antibodies

44
  • Diagnosis
  • Direct Coombs Test
  • Blood smear Spherocytosis Reticulocytosis
  • TREATMENT
  • Prednisone 1mg / kg / day
    orally
  • Azathioprine
  • Splenectomy

45
2)Preg. Induced hemolytic anemia
  • Unexplained hemolytic anemia uring pregnancy is
    rare
  • Severe hemolysis occurs early in pregnancy
    resolves within months after delivery
  • No evidence of immune mechanism or defects in
    RBCs
  • Prednisone given untill delivery
  • 3) Paroxysmal Nocturnal Hemoglobinuria
  • Acquired hemolytic anemia
  • Arises from one abnormal clone of cells like
    neoplasm
  • Anemia is insiduous in onset hemoglobinuria
    develoes at irregular intervals

46
  • Hemolysis may be initiated by transfusion ,
    infections or surgery
  • 40 suffer venous thrombosis, renal failure , HTN
    Budd Chiari syndrome.
  • Prophylactic anticoagulation is required
  • Bone marrow transplantation Definitive
    treatment
  • Effect on pregnancy
  • Serious unpredictable
  • Maternal mortality 10 20
  • Venous thrombosis occurs during post partum

47
APLASTIC ANAEMIA
  • Rarely seen in preg.
  • Marked decrease in marrow stem cels
  • ETIOLOGY
  • Infections
  • Irradiation
  • Leukemia
  • Immunological disorders

48
  • May be Immunological mediated or autosomal
    recessive inheritance
  • 30 cases Anaemia improves once pregnancy is
    terminated.
  • Complications
  • Infection
  • Haemorrhage

49
Diagnosis
  • Blood Values
  • Anemia
  • Leucopenia
  • Thrombocytopenia
  • Bone Marrow - Hypocellular

50
Management
  • Supportive care Cont. Infection surveillance
    anti microbial therapy
  • Red cell transfusions to maintain Hct. gt 20
  • Granulocyte transfusion given only during
    Infections
  • Platelet transfusion to control haemorrhage.
  • Glucocorticoid therapy may be helpful
  • IN SEVERE cases
  • Bone marrow or Stem Cell Transplantation
  • Vaginal delivery is preferred

51
  • Effect of anaemia in preg.
  • In MOTHER
  • During preg.
  • Pre eclampsia
  • Infectuion
  • Heart failure
  • Pretem labour
  • Labour
  • Uterine inertia
  • Postpartum Haemorrhage
  • Cardiac failure
  • Shock
  • Puerperium
  • Puerperal sepsis
  • Subinovulation
  • Failure of lactation
  • Puerperal venous thrombosis

52
  • Fetus
  • Amount of iron transferred to fetus is unaffected
    even if mother is in iron deficient state
  • Prematurity
  • Low birth weight babies
  • Intra uterine deaths due to severe maternal
    anoxemia

53
  • Effect of pregnancy in anaemia
  • Pt. Mildly anemic progresses to marked Anaemia
  • Pt. Who is severely anemic becomes symptomatic by
    the end of 2nd trimester

54
DIAGNOSIS OF ANEMIA DURING PREGNANCY
55
PLATELET DISORDERS
  • Thrombocytopenia - Gestational
  • - Immune
    mediated
  • Mild 1,50,000 1,00,000
  • Moderate 1,00,000 50,000
  • Severe - lt 50,000
  • Abnormalities of Platelet function

56
Causes of Thrombocytopenia during Pregnancy
  • COMMON CAUSES
  • Gestational Thrombocytopenia
  • Severe Pre-eclampsia
  • HELLP syndrome
  • Immune thrombocytopenic Purpura
  • Disseminated Intravascular coagulation
  • RARE CAUSES
  • Lupus anticoagulant/APA syndrome
  • SLE
  • Hemolytic Uremic Syndrome
  • Type 2b Von- Willebrands syndrome
  • Folic acid def.
  • HIV infections
  • Hemotoligical malignancies
  • May Hegglin syndrome Congenital
    Thrombocytopenia

57
Gestational Thrombocytopenia
  • Benign Common disorder
  • Appears in 8 of all preg.
  • Unknown cause
  • Rarely drops lt 70,000 /mm3
  • FEATURES
  • Diagnosis of Exclusion No specific test
    available
  • Mild Thrombocytopenia , Count gt 70,000 1 lakh
  • No maternal bleeding
  • No past history of thrombocytopenia
  • Occurs in 3rd trimester
  • No assoc. fetal thrombocytopenia
  • Spont. Resolution after delivery
  • May reccur in subsequent pregnancies

58
Management
  • Majority cases treated as normal
  • In mod. To severe cases Reluctance of
    Anaesthesiologists to give spinal or epidural if
    Platelets lt 80,000 /cu mm
  • Treatment with steroids IgG or platelet
    transfusion before delivery
  • Cord sample should be taken
  • Samples taken on day 1 4
  • CS reseved for obstetric indications

59
Immune Thrombocytopenia
  • Chronic condition , Incidence 1 in 1000 to 1 in
    10000 pregnancies
  • Charecterised by autoantibody mediated
    destruction of maternal platelets
  • MECHANISM
  • Autoanti bodies react with platelet Glycoprotein
    complex antibody coated platelets are
    phagocytosed by Macrophages

60
  • SYMPTOMS
  • Usually asymptomatic , sometimes Bleeding ,
    Petechiae
  • DIAGNOSIS
  • Plat count lt 50,000 / cu mm with past h/o
    bleeding disorders
  • No specific diagnostic test

61
Prepregnancy counselling for ITP ( RCOG 2009 )
  • May relapse or worsen
  • If treatment reqd, it will carry for both
    maternal fetal risks
  • Increased risk of Hemorrhage at delivery
  • Epidural Anaesthesia is not possible
  • Risk prediction in neonate is not possible. High
    risk if sibling has thrombocytopenia or mother
    has undergone splenectomy
  • Maternal deaths / serious outcome RARE
  • Risk of Intracranial Haemorrhage in fetus is very
    low.

62
Management
  • Adequate Plat. Count should be maintained
  • Counts monitored throughout pregnancy
  • If gt 30,000 No treatment
  • Iflt 30,000 - 1 ) Prednisolone 1 -2 mg / kg oral
    daily,
  • 2) IV IG 2g/kg over 2
    to 5 days , If no response then
  • 3) Splenectomy
  • 4) Immunosuppressive
    drugs like
  • a)
    azathioprine
  • b)
    Cyclophosphamide , Cyclosporine

63
Management Of delivery
  • Platelet gt 50,000 / cu mm Vaginal or operative
    delivery
  • Platelet 50,000 ? Platelets standby
  • CS not routinely recommende
  • Measures should be taken to avoid trauma to baby
    head
  • Cord sample taken, If low ? confirmed by
    capillary sample
  • If count low, further day 1 4 is collected
  • Inj im Vit K avoided till count is known

64
Fetal Neonatal Effects
  • PA IgG antibodies crosss placenta ? causes fetal
    neonatal Thrombocytopenia
  • Maternal treatment do not have effect o fetal
    count
  • Role of Intracaranial hemorrhage lt 1

65
MICROANGIOPATHIES
  • Thrombotic thrombocytopenic purpura
  • Rare life threatening
  • Signs symptoms ( PENTAD )
  • Microangiopathic hemolytic anemia
  • Thrombocytopenia
  • Neurological symptoms
  • Renal dysfunction
  • Fever

66
  • ETIOLOGY
  • Severe def. of VON WILLIBRAND FACTOR ( cleaving
    protein ( ADAM TS13)
  • Acqd ? autoantibody
  • Congenital ? Genetic defect
  • Incidence
  • 1 in 25000 pregnancies
  • Time of onset of TTP is variable
  • 1st trimester to several wks post partum
  • Maternal mortality is high

67
MANAGEMENT
  • ACQUIRED
  • Plasma Exchange
  • Fresh frozen Plasma infused daily until Platelets
    turn to Normal
  • Rituximab, Monoclonal antibodies against CD20
  • CONGENITAL
  • FFP
  • Platelet transfusion contraindicated

68
HEMOLYTIC UREMIC SYNDROME
  • Microangiopathic hemolytic anaemia
    thrombocytopenia with predominant Renal
    involvement
  • Due to endothelial damage by bacterial or viral
    infections
  • In Preg. Response is poor for plasma exchange

69
THROMBOCYTOSIS
  • Defined as persistant Platelet count gt4.5 lakhs /
    cumm
  • CAUSES
  • 1 )Secondary or Reactive ( gt 80000)
  • a)Iron def.
  • b) Infections
  • c) Splenectomy
  • d) Surgery Trauma ( bone fractures )
  • e) Malignancy
  • 2) Essential Thrombocytosis gt I million
  • a) Idiopathic
  • b) Myelodysplastic syndromes

70
  • SIGNS SYMPTOMS
  • Usually asymptomatic
  • Arterial venous Thrombosis
  • Hepatomegaly
  • Bone marrow Hyperplastic with gross increase in
    megakaryocytes
  • Blood picture -gt1 million
  • Leucocytosis
  • Anemia or mild
    polycythemia
  • Anisocytosis
    Poikilocytosis

71
  • In Pregnancy Spont. Abortion , fetal demise
    preeclampsia.
  • TREATMENT
  • Aspirin , Dipyramidole, Heparin, Plateletpheresis
  • PROGNOSIS depends on underlying disease
  • Death due to either thrombosis / hemorrhage /
    comp of Myeloproliferative disorders/ marrow
    failure.
Write a Comment
User Comments (0)
About PowerShow.com